Leung, W., Roxanis, I., Sheldon, H., Buffa, F. M., Li, J., Harris, A. L., & Kong, A. (2015). Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer. Oncotarget.

Leung, Wing-yin, Ioannis Roxanis, Helen Sheldon, Francesca M. Buffa, Ji-Liang Li, Adrian L. Harris, et Anthony Kong. "Combining Lapatinib and Pertuzumab to Overcome Lapatinib Resistance Due to NRG1-mediated Signalling in HER2-amplified Breast Cancer." Oncotarget 2015.

Leung, Wing-yin, et al. "Combining Lapatinib and Pertuzumab to Overcome Lapatinib Resistance Due to NRG1-mediated Signalling in HER2-amplified Breast Cancer." Oncotarget 2015.